III 

117TH CONGRESS 

2D SESSION S. RES. 648 

Designating May 2022 as ‘‘National Brain Tumor Awareness Month’’. 

IN THE SENATE OF THE UNITED STATES 

MAY 24, 2022 

Mr. DAINES (for himself, Mr. MARKEY, Ms. SINEMA, Mr. VAN HOLLEN, Mr. 

KELLY, and Ms. WARREN) submitted the following resolution; which was 

considered and agreed to 

RESOLUTION 

Designating May 2022 as ‘‘National Brain Tumor Awareness 

Month’’. 

Whereas more than an estimated 88,970 individuals will be 

diagnosed with a primary brain tumor in the United 

States in 2022, and an estimated 84,000 individuals in 

the United States were diagnosed with a primary brain 

tumor in 2021; 

Whereas an estimated 700,000 individuals are living with a 

brain tumor in the United States; 

Whereas in the United States, brain tumors are the— 

(1) leading cause of death from cancer in children 

who are under 14 years of age and teens who are under 

19 years of age; and 

(2) second leading cause of death from cancer in 

young adults who are between 15 and 39 years of age; 


kjohnson on DSK79L0C42PROD with BILLS
2 

•SRES 648 ATS 

Whereas the average 5-year survival rate for an individual in 

the United States following the diagnosis of a primary 

malignant brain tumor is only 35.6 percent; 

Whereas it is estimated that 18,200 individuals in the United 

States will die as a result of a malignant brain tumor in 

2022; 

Whereas brain tumors may be malignant or benign but can 

be life-threatening in either case; 

Whereas, as of the date of introduction of this resolution, approximately 700,000 individuals in the United States are 

living with a brain tumor; 

Whereas treatment of brain tumors is complicated by the fact 

that more than 100 types of brain tumors exist; 

Whereas the treatment and removal of brain tumors present 

significant challenges due to the uniquely complex and 

fragile nature of the brain; 

Whereas brain tumors affect the primary organ in the human 

body that controls not only cognitive ability, but the actions of every other organ and limb in the body, leading 

to brain tumors being described as a disease that affects 

the whole individual; 

Whereas brain tumor research is supported by a number of 

private, nonprofit research foundations and by Federal 

medical research institutions; 

Whereas basic research may fuel advancements and development of new treatments for brain tumors; 

Whereas obstacles to the development of new treatments for 

brain tumors remain, and there are limited strategies for 

the screening or early detection of brain tumors; 


kjohnson on DSK79L0C42PROD with BILLS
3 

•SRES 648 ATS 

Whereas, despite the high number of individuals diagnosed 

with a brain tumor every year and the devastating prognoses for those individuals, only 5 drugs and 1 medical 

device are approved by the Food and Drug Administration to treat primary brain tumors; 

Whereas the mortality rates associated with brain tumors 

have changed little during the 30-year period preceding 

the date of introduction of this resolution; 

Whereas there is a need for greater public awareness of brain 

tumors, including the difficulties associated with research 

on brain tumors and the opportunities for advances in 

brain tumor research and treatment; and 

Whereas May 2022, during which brain tumor advocates nationwide unite in awareness, outreach, and advocacy activities, is an appropriate month to recognize as ‘‘National Brain Tumor Awareness Month’’: Now, therefore, 

be it 

1 Resolved, That the Senate— 

2 (1) designates May 2022 as ‘‘National Brain 

3 Tumor Awareness Month’’; 

4 (2) encourages increased public awareness of 

5 brain tumors to honor the individuals who have lost 

6 their lives to a brain tumor or currently live with a 

7 brain tumor diagnosis; 

8 (3) supports efforts to develop better treat9 ments for brain tumors that will improve the quality 

10 of life and the long-term prognoses of individuals di11 agnosed with a brain tumor; 


kjohnson on DSK79L0C42PROD with BILLS
4 

•SRES 648 ATS 

1 (4) expresses its support for individuals who are 

2 battling brain tumors, as well as the families, 

3 friends, and caregivers of those individuals; and 

4 (5) urges a collaborative approach to brain 

5 tumor research, which is a promising means of ad6 vancing understanding of, and treatment for, brain 

7 tumors. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS